BG97123A - Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа - Google Patents

Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа Download PDF

Info

Publication number
BG97123A
BG97123A BG097123A BG9712392A BG97123A BG 97123 A BG97123 A BG 97123A BG 097123 A BG097123 A BG 097123A BG 9712392 A BG9712392 A BG 9712392A BG 97123 A BG97123 A BG 97123A
Authority
BG
Bulgaria
Prior art keywords
lipase
derivatives
pharmaceutical compositions
compositions based
bile salts
Prior art date
Application number
BG097123A
Other languages
English (en)
Other versions
BG61165B1 (bg
Inventor
Gunnar Bjursell
Lars Blaeckberg
Peter Carlsson
Sven Enerbaeck
Olle Hernell
Jeanette Nilsson
Thomas Olivecrona
Original Assignee
Arexis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arexis Ab filed Critical Arexis Ab
Publication of BG97123A publication Critical patent/BG97123A/bg
Publication of BG61165B1 publication Critical patent/BG61165B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1. Протеин, включващ следната аминокиселинна последователност от позиция 1 до 722: 37 претенции, 6 фигури
BG97123A 1990-06-01 1992-11-26 Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа BG61165B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products
PCT/SE1991/000381 WO1991018923A1 (en) 1990-06-01 1991-05-30 Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
BG97123A true BG97123A (bg) 1993-12-24
BG61165B1 BG61165B1 (bg) 1997-01-31

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97123A BG61165B1 (bg) 1990-06-01 1992-11-26 Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа

Country Status (44)

Country Link
EP (1) EP0535048B1 (bg)
JP (1) JPH05507201A (bg)
KR (1) KR100212411B1 (bg)
CN (2) CN1075113C (bg)
AP (1) AP207A (bg)
AT (1) ATE151077T1 (bg)
AU (1) AU651979B2 (bg)
BG (1) BG61165B1 (bg)
CA (1) CA2083396C (bg)
CZ (1) CZ287470B6 (bg)
DE (1) DE69125489T2 (bg)
DK (1) DK0535048T3 (bg)
DZ (1) DZ1503A1 (bg)
EG (1) EG19937A (bg)
ES (1) ES2099159T3 (bg)
FI (1) FI114639B (bg)
GR (1) GR3023618T3 (bg)
HK (1) HK62497A (bg)
HR (1) HRP920771B1 (bg)
HU (1) HU215258B (bg)
IE (1) IE911844A1 (bg)
IL (1) IL98273A (bg)
IS (1) IS1751B (bg)
JO (1) JO1694B1 (bg)
LT (1) LT4020B (bg)
LV (1) LV10292B (bg)
MA (1) MA22166A1 (bg)
MY (1) MY111245A (bg)
NO (1) NO322962B1 (bg)
NZ (1) NZ238223A (bg)
PH (1) PH30761A (bg)
PL (1) PL166534B1 (bg)
PT (1) PT97836B (bg)
RO (1) RO114793B1 (bg)
RU (1) RU2140983C1 (bg)
SE (1) SE9001985D0 (bg)
SG (1) SG48078A1 (bg)
SK (1) SK281089B6 (bg)
TN (1) TNSN91041A1 (bg)
TW (1) TW221712B (bg)
UA (1) UA39165C2 (bg)
WO (1) WO1991018923A1 (bg)
YU (1) YU49138B (bg)
ZA (1) ZA913778B (bg)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US20090226904A1 (en) * 2005-12-01 2009-09-10 University Of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes
FI3205351T3 (fi) 2010-04-23 2023-07-06 Alexion Pharma Inc Lysosomaalisen kertymätaudin entsyymi
KR20150038636A (ko) 2010-09-09 2015-04-08 시나게바 바이오파르마, 코포레이션 환자에서 리소좀 산 리파제 결핍증의 치료를 위한 리소좀 산 리파제의 용도
WO2012052060A1 (en) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Method to increase the growth velocity of human infants
EP2629789A1 (en) 2010-10-21 2013-08-28 Swedish Orphan Biovitrum AB (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
KR20200018781A (ko) * 2017-06-19 2020-02-20 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 반감기 연장 폴리펩티드를 갖는 융합 단백질
EP4501403A3 (en) 2019-08-30 2025-05-14 Société des Produits Nestlé S.A. Engineered lipase variants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000381A1 (en) * 1983-07-01 1985-01-31 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
MY111245A (en) 1999-10-30
TNSN91041A1 (fr) 1992-10-25
AP207A (en) 1992-08-18
MA22166A1 (fr) 1991-12-31
EP0535048A1 (en) 1993-04-07
CN1326782A (zh) 2001-12-19
CZ164491A3 (cs) 1999-07-14
NO924528L (no) 1992-11-24
CN1064313A (zh) 1992-09-09
PT97836A (pt) 1992-02-28
IL98273A (en) 2005-11-20
WO1991018923A1 (en) 1991-12-12
NO322962B1 (no) 2006-12-18
JPH05507201A (ja) 1993-10-21
SE9001985D0 (sv) 1990-06-01
ES2099159T3 (es) 1997-05-16
DZ1503A1 (fr) 2004-09-13
DE69125489T2 (de) 1997-08-14
YU95191A (sh) 1994-06-10
EG19937A (en) 2000-12-31
AU7964591A (en) 1991-12-31
HRP920771A2 (en) 1997-04-30
HU9203774D0 (en) 1993-03-29
ATE151077T1 (de) 1997-04-15
EP0535048B1 (en) 1997-04-02
CA2083396C (en) 2006-09-19
NO924528D0 (no) 1992-11-24
SG48078A1 (en) 1998-04-17
LT4020B (en) 1996-08-26
ZA913778B (en) 1992-02-26
FI114639B (fi) 2004-11-30
AP9100270A0 (en) 1991-07-31
YU49138B (sh) 2004-03-12
SK164491A3 (en) 1995-07-11
BG61165B1 (bg) 1997-01-31
DK0535048T3 (da) 1997-09-29
NZ238223A (en) 1993-05-26
UA39165C2 (uk) 2001-06-15
IS1751B (is) 2000-07-21
PH30761A (en) 1997-10-17
LV10292A (lv) 1994-10-20
KR100212411B1 (en) 1999-08-02
HK62497A (en) 1997-05-16
RO114793B1 (ro) 1999-07-30
SK281089B6 (sk) 2000-11-07
HRP920771B1 (en) 1999-10-31
IE911844A1 (en) 1991-12-04
HU215258B (hu) 1998-11-30
CN1075113C (zh) 2001-11-21
FI925453L (fi) 1992-11-30
IS3710A7 (is) 1991-12-02
HUT63184A (en) 1993-07-28
CZ287470B6 (cs) 2000-12-13
AU651979B2 (en) 1994-08-11
PT97836B (pt) 1998-11-30
IL98273A0 (en) 1992-06-21
RU2140983C1 (ru) 1999-11-10
TW221712B (bg) 1994-03-11
JO1694B1 (en) 1992-08-09
LTIP1736A (en) 1995-08-25
DE69125489D1 (de) 1997-05-07
GR3023618T3 (en) 1997-08-29
CA2083396A1 (en) 1991-12-02
PL166534B1 (pl) 1995-05-31
LV10292B (en) 1995-08-20
FI925453A0 (fi) 1992-11-30

Similar Documents

Publication Publication Date Title
DE69535963D1 (de) LHRH antagonistische Peptide
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
HUP9701059A2 (hu) Stronciumsók alkalmazása ízületi bántalmak kezelésére alkalmas gyógyszerkészítmények előállítására
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
RU94044534A (ru) Амино-производные тиазола, способы их получения и содержащие их фармацевтические композиции
MY106287A (en) Acid addition salts of amidated taurine or glycine, their preparation and use
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
DE3866045D1 (de) Arzneimittel zur behandlung von uraemie.
LV10108A (lv) Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
DK522582A (da) Peptider, deres fremstilling og anvendelse
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK0490383T3 (da) Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
EA199600048A3 (ru) N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.